Skip to main content

Teva launches prostate cancer treatment generic

Alaric DeArment
7/7/2009

NORTH WALES, Pa. Teva has introduced a generic version of a drug used to treat prostate cancer, the Israeli drug maker’s U.S. subsidiary announced Monday.

The company has launched bicalutamide tablets USP in the 50-mg strength. The tablets are a generic version of AstraZeneca’s Casodex.

Casodex had global sales of $1.26 billion in 2008, according to AstraZeneca financial data.

In other news, Teva announced Tuesday that it had agreed with Johnson & Johnson division Ortho McNeil Janssen to cease shipments of generic versions of Ortho Tri-Cyclen Lo (norgestimate and ethinyl estradiol) until a patent infringement case concerning the drug begins on July 15.

Related Topics

Popular Articles

FDA approves new indication for Novo Nordisk’s Ozempic

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 diabetes and chronic kidney disease.
ozempic

Kroger laying off corporate employees, Albertsons downsizes Safeway workforce

Kroger is cutting about 200 employees across three office sites, and Albertsons is laying off more than 150 Safeway corporate workers.
kroger

Eos engages all the senses with new launches, category expansions

Inside Beauty spoke to Jamie Sachs, vice president, product marketing and customer innovation at eos, to discuss its new launches.
eos cashmere body wash vanilla cashmere

Costco to raise hourly pay, reaches tentative agreement with union

Costco also is adding vacation time for new employees during their first year and giving workers with 30 years of employment an additional week of time off, per a CNN report.
costco teaser

Walgreens buyout talks reportedly unlikely to culminate in a deal

A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York private-equity firm Sycamore Partners is “mostly dead.”
walgreens
X
This ad will auto-close in 10 seconds